Compare RAPP & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPP | CRON |
|---|---|---|
| Founded | 2022 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2024 | N/A |
| Metric | RAPP | CRON |
|---|---|---|
| Price | $26.92 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $47.80 | N/A |
| AVG Volume (30 Days) | 427.2K | ★ 2.2M |
| Earning Date | 11-06-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $132,357,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | N/A | $30.76 |
| P/E Ratio | ★ N/A | $27.51 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $6.43 | $1.60 |
| 52 Week High | $42.27 | $3.43 |
| Indicator | RAPP | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 40.09 |
| Support Level | $26.30 | $2.65 |
| Resistance Level | $28.10 | $2.80 |
| Average True Range (ATR) | 1.80 | 0.08 |
| MACD | -0.37 | -0.02 |
| Stochastic Oscillator | 20.07 | 1.85 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.